High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresp...
High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases
About this item
Full title
Author / Creator
Publisher
Greece: D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
Greece: D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
Genetic testing is needed for the treatment of colorectal cancer (CRC), especially molecular-targeted therapy. The effects of anti-EGFR therapy and prognosis are affected by the presence of KRAS mutations. However, whether primary CRC or metastatic tissues are appropriate in the analysis is still unclear. In the present study, we assessed the conco...
Alternative Titles
Full title
High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1851298158
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1851298158
Other Identifiers
ISSN
1021-335X
E-ISSN
1791-2431
DOI
10.3892/or.2016.5323
